Crystals of solid phase-derived semisynthetic ribonuclease-S' were prepared and compared with those for native ribonuclease-S' and -S. The semisynthetic species used was the noncovalent complex of synthetic fragment1-20), corresponding to residues 1 through 20 of bovine pancreatic ribonuclease-A (ribonucleate 3'-pyrimidino-oligonucleotidohydrolase, EC 3.1.4.22), and native ribonuclease-S-(21-124), the fragment containing residues 21 through 124 of ribonuclease-A. This semisynthetic complex was completely active enzymatically, was homogeneous as judged by polyacrylamide gel electrophoresis, and had no greater than trace amounts of excess ribonuclease-S-21-124) as judged by affinity chroma- 
the fragment containing residues 21 through 124 of ribonuclease-A. This semisynthetic complex was completely active enzymatically, was homogeneous as judged by polyacrylamide gel electrophoresis, and had no greater than trace amounts of excess ribonuclease-S-21-124) as judged by affinity chromatography. Crystallization of both semisynthetic and native ribonuclease-S' at pH 5.3 resulted in well-formed crystals with the symmetry of space group P3121 and unit cell dimensions a = b = 44.82, c = 97. 3 A. This crystal form corresponds to the Y form of native ribonuclease-S previously reported [Wyckoff et a].
(1967)1. Biol. Chem. 242, 3749-37531. X-ray diffraction patterns of the crystals were indistinguishable, indicative of the structural identity of semisynthetic and native ribonuclease-S'. The ability to prepare synthetic proteins with a planned chemical mutation of important residues is of potential importance in the elucidation and engineering of conformational and functional features of proteins. Obtaining such species generally is limited by technical problems encountered in the synthesis and purification of large polypeptides to a state which will allow detailed characterization. One approach to circumvent these difficulties is to synthesize peptide fragments which can combine integrally with complementary native fragments to yield semisynthetic protein complexes (1) (2) (3) (4) (5) (6) . In this way, synthesis can be carried out for relatively small peptides and the products obtained allow the direct study of proteins.
We previously (7, 8) have prepared a semisynthetic ribonuclease-S' (SRNase-S')t, a noncovalent complex containing solid phase-derived synthetic fragment- (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) the preparation of analogues (7, 10, 11) . These studies have increasingly emphasized the desirability of being able to elucidate detailed structural features of semisynthetic analogues. One method useful for achieving such a goal is x-ray diffraction analysis of crystalline protein. The present study was carried out to demonstrate the ability to prepare crystals of normalsequence SRNase-S' and to compare the x-ray diffraction patterns for such crystals with those for native ribonuclease-S' (RNase-S').
MATERIALS AND METHODS General Procedures. RNase-S, the constituent fragments RNase-S-(1-20) and RNase-S-(21-124), and the reconstituted RNase-S' complex all were obtained from bovine pancreatic ribonuclease A (RNase-A) essentially as cited previously (7, 12) . The assay for RNase activity against cytidine 2':3'-cyclic monophosphate, as well as that for determination of amino acid composition of peptides after acid hydrolysis, have been described (7) .
Polyacrylamide gel electrophoresis of RNase species was carried out with 15% gels at pH 4.3 (13, 14) . Gels were stained with Coomassie blue.
Affinity chromatographic analysis was carried out by the competitive elution method (15) . RNase species were eluted on Sepharose-5'-(4-aminophenylphosphoryl)-uridine-2'(3')-phosphate) columns (0.9 X 8 cm) with 50,gM cytidine 2'-monophosphate in 0.4 M NH4OAc at pH 5.17 .
Preparation of SRNase-S'. The chemical synthesis of the peptide synthetic- (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , corresponding to the normal sequence of the amino terminal RNase-S-(1-20) fragment, was carried out by the solid phase method (16, 17) , as modified previously for the synthesis of synthetic-(1-15) fragments (7). The protected Na-t-butyloxycarbonyl amino acid derivatives used, as well as the method for cleavage and deblocking, have been defined (7) . After Sephadex G-25 fractionation, the crude synthetic-(1-20) peptide gave an amino acid composition close to that expected and was about 20% enzymically active when assayed after addition of equimolecular amounts of RNase-S-(21-124).
Normal sequence SRNase-S' was prepared from crude synthetic- (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) and RNase-S-(21-124) by a procedure analogous to that developed for other SRNase-S' species (7, 8) . The synthetic and native polypeptides were added in a molar ratio of 1.3:1 and the resulting complex was purified by sulfoethylSephadex chromatography followed by desalting on Sephadex-G-25.
Crystallization of SRNase-S' and Related Native Complexes. The conditions used for crystallization are similar to those used for native RNase-S by Wyckoff et al. (18, 19 The gel electrophoretic analysis of the semisynthetic complex was carried out by comparison with native RNase-S'. The resulting gels, shown in Fig. 1 , indicate the electrophoretic homogeneity of SRNase-S'.
As a further check of homogeneity, SRNase-S' was chromatographed on Sepharose-5'-(4-aminophenylphosphoryl)-uridine-2'(3')-phosphate under competitive elution conditions (see Materials and Methods). The results indicate the presence of a trace amount of unretarded material and the elution of the semisynthetic complex in one peak with the same position found for native RNase-A and -S. Material in the unretarded peak showed enzyme activity upon addition of excess RNase-S- (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) ; this activity indicates the presence of a small amount of excess RNase-S-(21-124) (<5%) in the SRNase-S' preparation obtained from sulfoethyl-Sephadex chromatography.
SRNase-S' was dissociated into component fragments by Sephadex G-75 fractionation in 50% acetic acid (9) . The recovered synthetic-(1-20) peptide gave an amino acid composition which is in close agreement (b6%) with that obtained with RNase-S-(1-20).
Crystallography of SRNase-S'
When SRNase-S' was crystallized at pH 5.3, several large and many small crystals were obtained. A representative photograph of some of these crystals is shown in Fig. 2 Crystals of the Y form also could be obtained for SRNase-S' at pH 6.1. However, in this study, crystallization of native RNase-S', and -S, at pH 6 Fig. 3 ). This indicates that these species are isomorphous. This iso- morphism indicates that SRNase-S' has a detailed three-dimensional conformation identical with that of the native complex.
Our data reinforce the contention, which we have made previously from data in solution (8, 20) , that SRNase-S', of a quality needed for detailed protein characterization, can be obtained via the solid phase synthesis route. It now appears possible, for important analogues of SRNase-S' made by amino acid replacement or deletion, to study structural properties by x-ray diffraction analysis, provided that crystals of such complexes can be obtained. Correlation of these structures with the known structure of native RNase-S could be particularly useful in understanding ribonuclease conformation and function.
